BioSpace News Archive

Business

CRF Health Extends Product Strategy and Innovation Team With Industry Pioneer

CRF Health has today announced the appointment of Bill Byrom as Vice President of Product Strategy & Innovation.

February 12, 2018

·

2 min read

Biotech Bay

Quartzy Launches Extensive Online Product Catalog of Over 2 Million Lab Supplies From More than 600 Manufacturers

Quartzy also announced the opening of a warehouse in Redwood City, CA to store supplies from vendors and ensure they get to labs as quickly and efficiently as possible.

February 12, 2018

·

3 min read

Innovative Medical Devices for the Treatment of Diabetes, Defymed Strengthens Its Position as a Worldwide Leader

As part of this approach, two innovative medical devices, ExOlin® and MailPan®, have been developed by Defymed to provide patients with a more physiological treatment.

February 12, 2018

·

2 min read

Policy

Intellipharmaceutics Meets with FDA Regarding Oxycodone ER NDA Development Program

Intellipharmaceutics today announced that it held a meeting with the United States FDA regarding the Company’s abuse-deterrent oxycodone hydrochloride extended release tablets product candidate.

February 12, 2018

·

7 min read

Drug Development

CBSET Release: Preclinical Safety Studies Must Include Equally Balanced Male/Female Animal Models to Shed Light on Sex-Dependent Vascular Responses in Humans

While the influence of sex on clinical outcomes is widely studied, many challenges remain.

February 12, 2018

·

3 min read

Drug Development

Intercept Announces Phase III REVERSE Trial Evaluating OCA for the Treatment of NASH Patients With Compensated Cirrhosis

REVERSE is a randomized, double-blind, placebo-controlled, multi-center study that will evaluate the efficacy and safety of the investigational therapy OCA in approximately 540 patients with a biopsy-confirmed diagnosis of cirrhosis due to NASH.

February 12, 2018

·

7 min read

Business

Daré Bioscience Enters into License and Collaboration Agreement for a Product with the Potential to Receive the First FDA Approval for Female Sexual Arousal Disorder

FSAD is characterized primarily by an inability to attain or maintain sufficient physical sexual arousal that causes distress or interpersonal difficulty.

February 12, 2018

·

5 min read

Business

Sera Prognostics: Key Strategies for Implementing Proteomics-Based Tests Across Disease States Highlighted in Current Opinion in Biotechnology

The paper will be printed in the June issue of Current Opinion in Biotechnology.

February 12, 2018

·

6 min read

Biotech Beach

Capricor to Give Update on HOPE-2 Clinical Trial for CAP-1002 at International Conference on Duchenne Muscular Dystrophy

The three-day conference brings together scientists, physicians, companies, patients and their families to discuss the latest developments in Duchenne and Becker muscular dystrophy.

February 12, 2018

·

4 min read

PositiveID’s Chief Science Officer Co-Authors Report on Need for Department of Homeland Security’s National Biosurveillance Integration Center

NBIC was established to help thwart the real threat of bioterrorism attacks in the U.S.

February 12, 2018

·

4 min read